Splash Beverage Group Acquires Exclusive Global Rights to CannEpil®, an Epilepsy Therapy with Established European Patient Access, FDA Engagement and U.S. Development Potential

Detailed price information for Splash Beverage Group Inc (SBEV-A) from The Globe and Mail including charting and trades.